Tag: congress

11 May 2018
img

As President Donald Trump gives his big speech on drug prices today, we're going to highlight a young candidate for U.S. Congress who is clearly on the side of the people on the issue of drug prices. Ryan Watts, Democratic candidate for Congress in the 6th District of North Carolina, became the first candidate to complete the Prescription Justice Drug Prices Policy Platform Questionnaire, a national bipartisan effort to provide members of Congress and candidates for statewide and federal offices an opportunity to state their position on the Prescription Justice policy platform(more…)

10 Apr 2018
img

A group of over 50 healthcare providers, including physicians, nurses and physician assistants, have come together to demand the federal government stop any action that would restrict access to lifesaving medications through personal prescription importation.

In a letter sent to President Donald Trump, members of Congress and the Food and Drug Administration (FDA), the healthcare providers expressed their alarm over FDA’s action in Florida against offices that primarily serve older Americans who prefer in-person assistance with purchasing medications from Canada and other countries, rather than using an internet site. Last year, FDA agents armed with search warrants notified the office owners that importing drugs is illegal and those who help “administer” such drugs could face fines or jail time. Yet, according to its owners, these offices do not dispense or administer medication to patients. (more…)

22 Jan 2018
img

Prescription Justice recently joined with nine other health, social justice and consumer advocacy organizations to launch a petition to demand Congress act to bring relief to the millions of Americans who can't afford the prescription drugs they need. 

The online petition largely echoes the Prescription Justice policy platform which prioritizes ending the ban on Medicare negotiating drug prices, making pay-for-delay deals illegal, and permitting wider access to lower-cost, imported medication through legislative, regulatory, and policy reforms. (more…)

20 Dec 2017
img

As we leave 2017 behind, the crisis of high prescription drug prices continues to threaten the health and well-being of Americans who struggle to access life-saving medications. Millions of Americans are forced to choose between taking the medicine they need, paying the rent or buying food for their families; tens of millions don't take prescribed medication; and federal and state budgets are overwhelmed. At Prescription Justice, we are dedicated solely to putting an end to this devastating crisis.

Over the past year, we have concentrated our efforts and resources on advocating for regulatory and legislative reforms and commonsense policies to lower domestic drug prices and expand access to lower cost medication from pharmacies in other countries. (more…)

08 Dec 2017
img

Last week, Gabriel Levitt, founder of Prescription Justice, published an Op-Ed in The Guardian about Alex Azar, President Trump's nominee for Secretary of the Department of Health and Human Services (HHS). Mr. Levitt's Op-Ed, Alex Azar is big pharma personified. He must not become US health secretary, underscores the urgent need for members of Congress to oppose Azar's confirmation.

(more…)

21 Sep 2017
img

During recent testimony before the Senate Health, Education, Labor and Pension Committee hearing on Stabilizing the Affordable Care Act Marketplace, AARP became the largest consumer organization to publicly support the prescription drug policy solutions reflected in Prescription Justice’s policy platform. AARP supports commonsense policy reforms to allow Medicare to negotiate drug prices, end pay-for-delay deals that delay entry of generic drugs into the marketplace, and increase access to lower cost medications through safe prescription drug importation. As part of a larger set of priorities for protecting and strengthening the healthcare system, AARP boldly declared that any changes to the healthcare law must include solutions to address rising prescription drug costs. (more…)

21 Jul 2017
img

The Prescription Justice coalition letter from last month, signed by a growing number of consumer, health and social justice organizations, supports S. 469/ H.R. 1245, The Affordable and Safe Prescription Drug Importation Act of 2017, introduced by Senator Bernie Sanders, I-VT and Representative Elijah Cummings, D-MD. If enacted, this bill would allow individuals, pharmacies and wholesalers to import FDA-approved medications from Canada, and then, after two years, from other countries with equally rigorous systems for regulating the safety and efficacy of pharmaceuticals.

Prescription Justice also supports S. 64 / H.R. 1480, The Safe and Affordable Drugs from Canada Act of 2017, introduced by Senator John McCain, R-AZ and Representative Chellie Pingree, D-ME. This bill would allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada. Prescription medications imported under this bill would be the same dosage, form, and potency as drugs in the U.S., but at a significant savings to Americans.

(more…)

08 Jun 2017
img

Prescription Justice is proud to announce that we have sent a letter to the U.S. Congress, signed by non-profit organizations dedicated to American consumers, patients and families who struggle with the high cost of medication. The letter specifically calls for the passage of the Affordable and Safe Prescription Drug Importation Act of 2017, introduced by Senators Cory Booker, Bob Casey, and Bernie Sanders. The Act would expressly allow importation of lower cost medications from Canada, and, after two years, other countries with strong pharmaceutical regulations. Uniquely, the letter also recognizes that Americans already import medication for personal use, often ordering them from international online pharmacies, regardless of the federal restrictions. That practice can be safe but rogue websites are a threat to patient safety. (more…)